FDA, Drugmakers Urge 5th Circ. To Allow Abortion Pill By Mail
The U.S. Food and Drug Administration and the makers of the abortion medication mifepristone have urged the Fifth Circuit not to reinstate an in-person dispensing requirement, arguing that doing so would...To view the full article, register now.
Already a subscriber? Click here to view full article